⚠ Czech Growth Is SlowingModerate threat

Synektik (SNT) — threat to the moat

Synektik's Czech and Slovak robots are busier than Poland's, and their growth is half as fast.

The handed-over territory is maturing faster than Poland. Czech and Slovak da Vinci procedures rose 18% in the April-June 2026 quarter, to 4,0 thousand, while Polish procedures rose 35%1. For the full year to September 2025 the Czech and Slovak figure grew 33% against 67% in Poland2.

da Vinci procedure growth, Apr-Jun 2026 (%)+35Poland+18Czechia and SlovakiaSynektik interim report, nine months to June 2026
The older territory is growing at half the pace.

That is partly arithmetic. The region already has one robot per 408 000 people against 505 000 in Poland3, so it has less catching up to do, and each new robot adds a smaller share to the base. The installed base grew from 38 to 42 systems in the nine months to June 202645, four robots in three quarters.

Slower growth matters because it is exactly the evidence a manufacturer looks at when it decides whether a distributor is still adding value. A mature, high-utilisation territory with a steady instrument stream is the kind Intuitive has shown it is willing to buy back elsewhere6.

The quarterly figures show the trend within the year: Czech and Slovak procedure growth was 23% in the October-December 2025 quarter7, 23% in the half-year to March8 and 18% in April-June 20269.

Single-digit procedure growth in Czechia and Slovakia would say the territory has become a service annuity rather than a growth market, and would give Intuitive a simpler business to take back.

References
  1. ReportedCzech and Slovak da Vinci procedures rose 18% in the April-June 2026 quarter, to 4,0 thousand, while Polish procedures rose 35%.
    Synektik S.A. and Synektik Group interim condensed financial statements for 1 October 2025 - 30 June 2026 (third quarter of the fiscal year) - management commentary: orders, backlog, da Vinci systems and procedures, recurring revenue, radiopharmaceutical sales and seasonality. — October 2025 - June 2026 · publ. 5 August 2026 · source ↗
  2. ReportedFor the full year to September 2025 the Czech and Slovak figure grew 33% against 67% in Poland.
    Synektik annual management board report for the fiscal year to 30 September 2025 - operating review: da Vinci systems and procedures, orders, recurring revenue, radiopharmaceutical products and the Baltic expansion. — October 2024 - September 2025 · publ. December 2025 · source ↗
  3. ReportedThe region already has one robot per 408 000 people against 505 000 in Poland, so it has less catching up to do, and each new robot adds a smaller share to the base.
    Synektik annual management board report for the fiscal year to 30 September 2025 - description of the markets: robotic surgery in Poland, PET scanners, cyclotrons and NFZ-funded PET studies. — October 2024 - September 2025 · publ. December 2025 · source ↗
  4. ReportedThe installed base grew from 38 to 42 systems in the nine months to June 2026, four robots in three quarters.
    Synektik annual management board report for the fiscal year to 30 September 2025 - operating review: da Vinci systems and procedures, orders, recurring revenue, radiopharmaceutical products and the Baltic expansion. — October 2024 - September 2025 · publ. December 2025 · source ↗
  5. ReportedThe installed base grew from 38 to 42 systems in the nine months to June 2026, four robots in three quarters.
    Synektik press release, 17 September 2026: 'Synektik signs first contract in Estonia. Another step in the Baltic states expansion' - EUR 9,4 million including nine years of maintenance and ten years of consumables; 142 systems (100 in Poland, 42 in Czechia and Slovakia); the Ukraine plan; targets for foreign and recurring revenue. — September 2026 · publ. 17 September 2026 · source ↗
  6. ReportedA mature, high-utilisation territory with a steady instrument stream is the kind Intuitive has shown it is willing to buy back elsewhere.
    Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11 710 da Vinci systems up 12%; the 1 March 2026 acquisition of the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for approximately $533,1 million in cash, with $279,8 million of intangible and other assets and $218,0 million of goodwill, making Intuitive the direct distributor in Italy, Spain and Portugal). Same document as Intuitive's own _IS_Q226 record. — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗
  7. ReportedThe quarterly figures show the trend within the year: Czech and Slovak procedure growth was 23% in the October-December 2025 quarter, 23% in the half-year to March and 18% in April-June 2026.
    Synektik interim financial statements for 1 October - 31 December 2025 - including the annex extending the da Vinci distribution agreement to 31 December 2031 and adding Ukraine, and the 10,75 złoty dividend. — October - December 2025 · publ. February 2026 · source ↗
  8. ReportedThe quarterly figures show the trend within the year: Czech and Slovak procedure growth was 23% in the October-December 2025 quarter, 23% in the half-year to March and 18% in April-June 2026.
    Synektik management board report for the half-year 1 October 2025 - 31 March 2026 - including the HistoSonics Edison exclusive distribution agreement and the installed base at March 2026. — October 2025 - March 2026 · publ. June 2026 · source ↗
  9. ReportedThe quarterly figures show the trend within the year: Czech and Slovak procedure growth was 23% in the October-December 2025 quarter, 23% in the half-year to March and 18% in April-June 2026.
    Synektik S.A. and Synektik Group interim condensed financial statements for 1 October 2025 - 30 June 2026 (third quarter of the fiscal year) - management commentary: orders, backlog, da Vinci systems and procedures, recurring revenue, radiopharmaceutical sales and seasonality. — October 2025 - June 2026 · publ. 5 August 2026 · source ↗
Sources
Generated September 24, 2026